» Articles » PMID: 33673068

Cost-Effectiveness of Two Dry Needling Interventions for Plantar Heel Pain: A Secondary Analysis of an RCT

Overview
Publisher MDPI
Date 2021 Mar 6
PMID 33673068
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Plantar heel pain is a common cause of foot pain that affects patients' quality of life and represents a significant cost for the healthcare system. Dry needling and percutaneous needle electrolysis are two minimally invasive treatments that were shown to be effective for the management of plantar heel pain. The aim of our study was to compare these two treatments in terms of health and economic consequences based on the results of a published randomized controlled trial. For this, we evaluated the costs from the point of view of the hospital and we carried out a cost-effectiveness study using quality of life as the main variable according to the Eq-5D-5L questionnaire. The cost of the complete treatment with dry needling (DN) was €178.86, while the percutaneous needle electrolysis (PNE) was €200.90. The quality of life of patients improved and was translated into +0.615 quality-adjusted life years (QALYs) for DN and +0.669 for PNE. PNE presented an average incremental cost-effectiveness ratio (ICER) of €411.34/QALY against DN. These results indicate that PNE had a better cost-effectiveness ratio for the treatment of plantar heel pain than DN.

Citing Articles

Botulinum Toxin and Percutaneous Needle Electrolysis for the Treatment of Chronic Masticatory Myalgia.

Gonzalez-Perez L, Vera-Martin R, Montes-Latorre E, Torres-Carranza E, Infante-Cossio P Toxins (Basel). 2023; 15(4).

PMID: 37104216 PMC: 10144780. DOI: 10.3390/toxins15040278.


Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report.

Javier-Ormazabal A, Herrero P, Gonzalez-Platas M Degener Neurol Neuromuscul Dis. 2023; 13:15-20.

PMID: 36733290 PMC: 9888012. DOI: 10.2147/DNND.S395082.


Dry Needling and Antithrombotic Drugs.

Munoz M, Dommerholt J, Perez-Palomares S, Herrero P, Calvo S Pain Res Manag. 2022; 2022:1363477.

PMID: 35035647 PMC: 8759918. DOI: 10.1155/2022/1363477.

References
1.
Tong K, Furia J . Economic burden of plantar fasciitis treatment in the United States. Am J Orthop (Belle Mead NJ). 2010; 39(5):227-31. View

2.
Al-Boloushi Z, Gomez-Trullen E, Bellosta-Lopez P, Lopez-Royo M, Fernandez D, Herrero P . Comparing two dry needling interventions for plantar heel pain: a protocol for a randomized controlled trial. J Orthop Surg Res. 2019; 14(1):31. PMC: 6347763. DOI: 10.1186/s13018-019-1066-4. View

3.
Devlin N, Shah K, Feng Y, Mulhern B, van Hout B . Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2017; 27(1):7-22. PMC: 6680214. DOI: 10.1002/hec.3564. View

4.
OBrien B, Briggs A . Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res. 2003; 11(6):455-68. DOI: 10.1191/0962280202sm304ra. View

5.
Al-Boloushi Z, Gomez-Trullen E, Arian M, Fernandez D, Herrero P, Bellosta-Lopez P . Comparing two dry needling interventions for plantar heel pain: a randomised controlled trial. BMJ Open. 2020; 10(8):e038033. PMC: 7440826. DOI: 10.1136/bmjopen-2020-038033. View